Loading
Topaz Therapeutics is a small, early company in San Francisco that says it is building a platform for new cancer drugs. It has not said publicly what those drugs are.
Topaz Therapeutics' website states only that it is developing a platform of next-generation oncology drugs; OrbiMed's portfolio page says the same. A company profile on Venrock's job board places it in San Francisco, lists 1 to 10 employees and says it is operating in stealth mode. No programmes, targets, trials or financing amounts have been made public.
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
A source that has moved or gone is reported by the weekly link check. /audit/